Tecan Group AG (TECN) - Total Assets

Latest as of June 2025: CHF1.94 Billion CHF ≈ $2.45 Billion USD

Based on the latest financial reports, Tecan Group AG (TECN) holds total assets worth CHF1.94 Billion CHF (≈ $2.45 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Tecan Group AG book value and equity for net asset value and shareholders' equity analysis.

Tecan Group AG - Total Assets Trend (2002–2024)

This chart illustrates how Tecan Group AG's total assets have evolved over time, based on quarterly financial data.

Tecan Group AG - Asset Composition Analysis

Current Asset Composition (December 2024)

Tecan Group AG's total assets of CHF1.94 Billion consist of 40.4% current assets and 59.6% non-current assets.

Asset Category Amount (CHF) % of Total Assets
Cash & Equivalents CHF154.19 Million 7.3%
Accounts Receivable CHF195.78 Million 9.2%
Inventory CHF230.50 Million 10.9%
Property, Plant & Equipment CHF147.33 Million 6.9%
Intangible Assets CHF308.31 Million 14.5%
Goodwill CHF760.96 Million 35.9%

Asset Composition Trend (2002–2024)

This chart illustrates how Tecan Group AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see TECN stock market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Tecan Group AG's current assets represent 40.4% of total assets in 2024, a decrease from 73.7% in 2002.
  • Cash Position: Cash and equivalents constituted 7.3% of total assets in 2024, down from 25.7% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 8.0% in 2002.
  • Asset Diversification: The largest asset category is goodwill at 35.9% of total assets.

Tecan Group AG Competitors by Total Assets

Key competitors of Tecan Group AG based on total assets are shown below.

Company Country Total Assets
Alcon AG
SW:ALC
Switzerland CHF31.53 Billion
iRay Technology Co Ltd
SHG:688301
China CN¥11.33 Billion
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
China CN¥2.42 Billion
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
USA $32.49 Million
Jiangsu Nanfang Medical
SHG:603880
China CN¥993.46 Million
SDI Ltd
AU:SDI
Australia AU$141.20 Million
MEDIMI AB AK
F:79T
Germany €1.70 Million
I.Ceram SA
PA:ALICR
France €3.91 Million

Tecan Group AG - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.61 2.87 3.73
Quick Ratio 1.18 1.92 2.79
Cash Ratio 0.51 0.37 1.09
Working Capital CHF307.66 Million CHF552.48 Million CHF474.17 Million

Tecan Group AG - Advanced Valuation Insights

This section examines the relationship between Tecan Group AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.32
Latest Market Cap to Assets Ratio 0.81
Asset Growth Rate (YoY) 2.3%
Total Assets CHF2.12 Billion
Market Capitalization $1.72 Billion USD

Valuation Analysis

Near Book Valuation: The market values Tecan Group AG's assets close to their book value (0.81x), suggesting investors view the company's assets at approximately fair value.

Positive Asset Growth: Tecan Group AG's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Tecan Group AG (2002–2024)

The table below shows the annual total assets of Tecan Group AG from 2002 to 2024.

Year Total Assets Change
2024-12-31 CHF2.12 Billion
≈ $2.68 Billion
+2.29%
2023-12-31 CHF2.07 Billion
≈ $2.62 Billion
-4.00%
2022-12-31 CHF2.16 Billion
≈ $2.73 Billion
+5.70%
2021-12-31 CHF2.04 Billion
≈ $2.58 Billion
+80.79%
2020-12-31 CHF1.13 Billion
≈ $1.43 Billion
+20.30%
2019-12-31 CHF939.77 Million
≈ $1.19 Billion
+9.57%
2018-12-31 CHF857.67 Million
≈ $1.08 Billion
+6.68%
2017-12-31 CHF803.96 Million
≈ $1.02 Billion
+9.21%
2016-12-31 CHF736.16 Million
≈ $930.71 Million
+14.76%
2015-12-31 CHF641.48 Million
≈ $811.01 Million
+16.16%
2014-12-31 CHF552.26 Million
≈ $698.21 Million
+18.35%
2013-12-31 CHF466.65 Million
≈ $589.97 Million
+10.76%
2012-12-31 CHF421.30 Million
≈ $532.64 Million
+8.04%
2011-12-31 CHF389.94 Million
≈ $492.99 Million
+15.20%
2010-12-31 CHF338.50 Million
≈ $427.96 Million
-2.90%
2009-12-31 CHF348.62 Million
≈ $440.75 Million
+6.98%
2008-12-31 CHF325.86 Million
≈ $411.98 Million
-12.87%
2007-12-31 CHF373.98 Million
≈ $472.81 Million
+2.29%
2006-12-31 CHF365.60 Million
≈ $462.22 Million
+8.16%
2005-12-31 CHF338.01 Million
≈ $427.33 Million
+76.68%
2004-12-31 CHF191.31 Million
≈ $241.87 Million
-14.69%
2003-12-31 CHF224.25 Million
≈ $283.51 Million
-1.99%
2002-12-31 CHF228.81 Million
≈ $289.27 Million
--

About Tecan Group AG

SW:TECN Switzerland Medical Instruments & Supplies
Market Cap
$1.89 Billion
CHF1.49 Billion CHF
Market Cap Rank
#6818 Global
#92 in Switzerland
Share Price
CHF117.70
Change (1 day)
+1.99%
52-Week Range
CHF114.70 - CHF176.30
All Time High
CHF586.60
About

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, … Read more